XASX
BPH
Market cap7mUSD
Dec 05, Last price
0.01AUD
1D
0.00%
1Q
-35.71%
Jan 2017
-72.33%
IPO
-99.64%
Name
BPH Energy Ltd
Chart & Performance
P/E
2.41
P/S
13.01
EPS
0.00
Div Yield, %
—
Shrs. gr., 5y
37.53%
Rev. gr., 5y
24.84%
Revenues
844k
+177.48%
Net income
5m
+433.96%
CFO
-942k
L-10.38%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
BPH Energy Limited invests in biotechnology, oil and gas exploration and development, and medicinal cannabis industries in Australia. The company is building a system to generate clean hydrogen and conductive carbon used to manufacture batteries for commercial use. It also offers brain anaesthesia response monitoring system, a device to detect the effect of anaesthetic agents on brain activity and assist anaesthetists in keeping patients optimally anaesthetised. In addition, the company invests in the biomedical research of HLS5 tumour suppressor gene for liver cancer. Further, it holds a 100% interest in RL1 oil and gas assets located in the onshore Bonaparte basin in northern Australia; and 85% interest in the petroleum exploration permit 11 asset situated in the offshore Sydney basin. The company was formerly known as BioPharmica Limited. BPH Energy Limited was incorporated in 2001 and is headquartered in Stirling, Australia.
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | 2016‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||